Clinical Trial Update: Orathecin + Gemcitabine Versus Placebo + Gemcitabine in Chemonaive Non-Resectable Pancreatic Cancer [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 trial comparing orathecin plus gemcitabine versus placebo plus gemcitabine in chemonaive non-resectable pancreatic cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Gemzar (gemcitabine)
• Orathecin (orathecin)

Snippet

Sponsor: Astex Pharmaceuticals, Inc. | Conditions: Pancreatic Cancer | Phase 2, Phase 3 | Status: TERMINATED